Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease
Author(s) -
Chris Pászty,
Catherine M. Brion,
Elizabeth A. Manci,
H. Ewa Witkowska,
Mary E. Stevens,
Narla Mohandas,
Edward M. Rubin
Publication year - 1997
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.278.5339.876
Subject(s) - transgene , sickle cell anemia , genetically modified mouse , disease , biology , hemoglobinopathy , fetal hemoglobin , cell , gene , knockout mouse , hemoglobin , globin , immunology , hemolytic anemia , genetics , medicine , pathology , biochemistry , pregnancy , fetus
To create mice expressing exclusively human sickle hemoglobin (HbS), transgenic mice expressing human alpha-, gamma-, and betaS-globin were generated and bred with knockout mice that had deletions of the murine alpha- and beta-globin genes. These sickle cell mice have the major features (irreversibly sickled red cells, anemia, multiorgan pathology) found in humans with sickle cell disease and, as such, represent a useful in vivo system to accelerate the development of improved therapies for this common genetic disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom